Aprogen Biologics Inc.

₩1,291As of Sun 8 Nov 2026, 12:00 UTC
KRX:003060Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (41.70%)
Div yield —
ROE (23.95%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) (0.21)
PE TTM —
TSR TTM (84.41%)
Mkt cap ₩20.89B
ROIC (21.62%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩1,269
(1.73%)
(51.27%)
Hold 6|9|6|0|9
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
13.00
14.43
15.56
15.97
(8.06%)
4.22%
16.44%
18.77%
Revenue₩B
1.809
1.779
1.808
1.803
8.33%
1.34%
0.14%
1.19%
Peers (US$15.40M)
Cap (US$)
PE
15.38M
5.562x
Capital
TTM
5Y
10Y
Leveragex
0.481
(0.171)
(0.193)
EBIT/Intx
1.274
0.499
0.423
Own earn%
(14.03)
(5.80)
8.13
Sh yield%
17.81
33.70
31.69
Owners
Insiders/Inst%
12.70
34.87
Short interest%
3.49
SBC / revenue%
4.12
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
6–14
$1 testx
—
Incr. ROIC%
144